Rubric Capital Management LP Innate Pharma Sa Transaction History

Rubric Capital Management LP

  • $3.59 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$3.85 - $5.62 $962,500 - $1.41 Million
-250,000 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$3.77 - $6.55 $2.57 Million - $4.46 Million
-681,673 Reduced 73.17%
250,000 $960,000
Q1 2020

May 14, 2020
SELL
$3.8 - $7.95 $1.59 Million - $3.33 Million
-418,327 Reduced 30.99%
931,673 $6.22 Million
Q4 2019

Feb 14, 2020
BUY
$5.66 - $6.55 $7.64 Million - $8.84 Million
1,350,000 New
1,350,000 $8.69 Million

Others Institutions Holding IPHA

# of Institutions
9
Shares Held
238K
Call Options Held
0
Put Options Held
0
View Full List

About Innate Pharma SA

IPHA Quotes by TradingView
  • Ticker IPHA
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,893,000
  • Market Cap $147M
  • Description
  • Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...
More about IPHA
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email